Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Premade Virus Particles
Ready-to-Use | High Titer | Versatile Applications
Premade AAV, adenovirus, lentivirus particles, safe, stable, in stock.
Virus-Like Particles (VLPs)
Stable | Scalable | Customizable
Advanced VLPs for vaccine development (Chikungunya, Dengue, SARS-CoV-2), gene therapy (AAV1 & AAV9), and drug screening (SSTR2, CCR5).
Oligonucleotide Products
Precise | High Yield | Tailored Solutions
Accelerate your research with cost-effective LncRNA qPCR Array Technology.
RNA Interference Products
Targeted | Potent | High Specificity
Human Druggable Genome siRNA Library enables efficient drug target screening.
Recombinant Drug Target Proteins
Authentic | Versatile | Accelerated
Providing functional, high-purity recombinant proteins—including membrane proteins and nanodiscs—to overcome bottlenecks in drug screening and target validation.
Clones
Validated | Reliable | Comprehensive Collection
Ready-to-use clones for streamlined research and development.
Kits
Complete | Convenient | High Sensitivity
Chromogenic LAL Endotoxin Assay Kit ensures precise, FDA-compliant endotoxin quantification for biosafety testing.
Enzymes
Purified | Stable | Efficient
Powerful Tn5 Transposase for DNA insertion and random library construction.
Aptamers
Highly Specific | Robust | Versatile
Aptamers for key proteins like ACVR1A, Akt, EGFR, and VEGFR.
Adjuvants
Enhancing | Synergistic | Effective
Enhance immune responses with high-purity, potent CpG ODNs.
Laboratory Equipment
Innovative | Reliable | High-Precision
Effortlessly streamline DNA extraction with CB™ Magnetic-Nanoparticle Systems.
Stable Cell Line Generation
Reliable | Scalable | Customizable
Fast proposals, regular updates, and detailed reports; strict quality control, and contamination-free cells; knockout results in 4-6 weeks.
Target-based Drug Discovery Service
Innovative | Comprehensive | Efficient
Target identification, validation, and screening for drug discovery and therapeutic development.
Custom Viral Service
Versatile | High-Yield | Safe
Unbeatable pricing, fully customizable viral packaging services (covering 30,000+ human genes, 200+ mammals, 50+ protein tags).
Custom Antibody Service
Precise | Flexible | Efficient
End-to-end antibody development support, from target to validation, enabling clients to rapidly obtain application-ready antibodies.
Antibody-Drug Conjugation Service
Integrated | Controlled | Translational
Comprehensive solutions covering design, development, and validation to ensure conjugated drugs with consistent quality and clinical potential.
Protein Degrader Service
Efficient | High-Precision | Advanced Therapeutics
Harness the power of protein degraders for precise protein degradation, expanding druggable targets and enhancing therapeutic effectiveness for cutting-edge drug discovery.
Nucleotides Service
Accurate | Flexible | High-Quality
Custom synthesis of oligonucleotides, primers, and probes for gene editing, PCR, and RNA studies.
Custom RNA Service
Custom RNA ServicePrecise | Flexible | GMP-ReadyCustom
RNA design, synthesis, and manufacturing—covering mRNA, saRNA, circRNA, and RNAi. Fast turnaround, rigorous QC, and seamless transition from research to GMP production.
Custom Libraries Construction Service
Comprehensive | High-throughput | Accurate
Custom cDNA, genomic, and mutagenesis libraries for drug discovery, screening, and functional genomics.
Gene Editing Services
Precise | Efficient | Targeted
Gene editing solutions for gene editing, knockouts, knock-ins, and customized genetic modifications. Integrated multi-platform solutions for one-stop CRISPR sgRNA library synthesis and gene screening services
Microbe Genome Editing Service
Precise | Scalable | Customizable
Enhance microbial productivity with advanced genome editing using Rec-mediated recombination and CRISPR/Cas9 technologies.
Biosafety Testing Service
Reliable | Comprehensive | Regulated
Complete biosafety testing solutions for gene therapy, viral vectors, and biologics development.
Plant Genetic Modification Service
Advanced | Sustainable | Tailored
Genetic modification for crop improvement, biotechnology, and plant-based research solutions.
Plant-based Protein Production Service
Efficient | Scalable | Customizable
Plant-based protein expression systems for biopharmaceuticals, enzyme production, and research.
Aptamers Service
Innovative | Fast | Cost-Effective
Revolutionizing drug delivery and diagnostic development with next-generation high-throughput aptamer selection and synthesis technologies.
CGT Biosafety Testing
Comprehensive | Accurate | Regulatory-compliant
Internationally certified evaluation system for biologics, gene therapies, nucleic acid drugs, and vaccines.
Pandemic Detection Solutions
Rapid | Precise | Scalable
Balancing accuracy, accessibility, affordability, and rapid detection to safeguard public health and strengthen global response to infectious diseases.
cGMP Cell Line Development
Reliable | Scalable | Industry-leading
Stable expression over 15 generations with rapid cell line development in just 3 months.
Supports adherent and suspension cell lines, offering MCB, WCB, and PCB establishment.
GMP mRNA Production
Efficient | Scalable | Precise
Scalable mRNA production from milligrams to grams, with personalized process design for sequence optimization, cap selection, and nucleotide modifications, all in one service.
GMP Plasmid Production
High Quality | Scalable | Regulatory-compliant
Our plasmid production services span Non-GMP, GMP-Like, and GMP-Grade levels, with specialized options for linearized plasmids.
GMP Viral Vector Manufacturing
Scalable | High Yield | Quality-driven
Advanced platforms for AAV, adenovirus, lentivirus, and retrovirus production, with strict adherence to GMP guidelines and robust quality control.
AI-Driven Gene Editing and Therapy
Innovative | Precision | Transformative
AI-powered one-click design for customized CRISPR gene editing strategy development.
AI-Antibody Engineering Fusion
Next-Generation | Targeted | Efficient
AI and ML algorithms accelerate antibody screening and predict new structures, unlocking unprecedented possibilities in antibody engineering.
AI-Driven Enzyme Engineering
Smart | Efficient | Tailored
High-throughput enzyme activity testing with proprietary datasets and deep learning models for standardized and precise enzyme engineering design.
AI-Enhanced Small Molecule Screening
Predictive | Efficient | Insightful
Leverage AI to uncover hidden high-potential small molecules, prioritize leads intelligently, and reduce costly trial-and-error in early drug discovery.
AI-Driven Protein Degrader Drug Development
Innovative | Targeted | Accelerated
Use AI-guided design to optimize protein degraders, addressing design complexity and enhancing efficacy while shortening development timelines.
Plant-based expression systems are evolving from so-called "alternative solutions" into an independent and increasingly important pillar of modern biomanufacturing. In scenarios where microbial or mammalian cell expression systems are constrained, plant-based platforms are demonstrating distinctive advantages in preserving complex protein structures, ensuring biosafety, and enabling cost-effective scale-up.
Built upon multiple plant expression modalities, Creative Biogene has established an integrated technology platform spanning gene design, expression strategy selection, scale-up production, protein purification, and quality characterization. We provide customized plant-derived recombinant protein services for global clients across both research and translational development stages.

Plant-based expression is not a "low-end substitute," but rather a differentiated solution, particularly suitable for the following applications:
Compared with conventional expression systems, plant-based platforms offer multiple systemic advantages. They feature a lighter cost structure, more flexible scale-up pathways, and an inherent absence of mammalian viral contamination risks. In addition, the unique organelle architecture of plant cells provides a cellular environment that more closely resembles native conditions for the proper folding and post-translational modification of complex proteins.
At the platform level, Creative Biogene has established a technology framework centered on plant cell–based expression and tissue-specific expression systems, further extended to encompass a broad range of plant-derived expression modalities.

Optimized plant cell suspension cultures enable efficient production of functional proteins, enzymes, and selected therapeutics, providing a reliable platform for pilot-scale production and downstream industrial applications.

Endosperm-specific promoters drive high protein accumulation without affecting plant growth. Proteins are stored in seeds, offering superior stability and ease of transport. This system is ideal for recombinant human serum albumin, vaccine antigens, and oral protein formulations.

Model plants like tobacco and lettuce provide flexible whole-plant platforms. Transient expression allows rapid protein production for feasibility studies, antigen screening, and early-stage research, while stable expression supports long-term protein supply through transgenic lines.

Creative Biogene also offers alternative plant-based systems to meet specialized needs, including:
In plant-based expression, technological differentiation lies not merely in the ability to achieve transformation, but in the capacity to operate a fully integrated and systematic platform. This includes early-stage feasibility assessment, rational expression strategy design, scalable process development, and consistent delivery of qualified protein products. Creative Biogene approaches plant expression as an end-to-end engineering system rather than a single experimental service, and has built a modular, combinable plant expression platform around this philosophy.
01 Expression Strategy Design and Project Feasibility Assessment
The success of plant-based expression is highly dependent on upfront strategic decisions. For each project, platform development begins with a systematic analysis of the target protein rather than immediate experimental execution.
02 Gene Design and Expression Construct Development
During the construct development phase, Creative Biogene employs a combination of standardized methodologies and customized design strategies to ensure both expression efficiency and system stability.
03 Plant Transformation and Expression Validation
Following construct assembly, the platform proceeds to plant system delivery and expression validation, serving as the critical bridge between design and production.
04 Scale-Up Expression and Process Optimization
For projects that pass expression validation, the platform offers scale-up and production-level process development support.
05 Protein Extraction, Purification, and Quality Characterization
The ultimate goal of the plant-based expression platform is to deliver functional, verifiable protein products rather than expression data alone.
Creative Biogene's plant-based expression platform supports multiple levels of collaboration, ranging from early feasibility validation to long-term production partnerships. Clients may select engagement models that best align with their development objectives.
Creative Biogene is committed to building plant-based expression platforms into a critical bridge between fundamental research and industrial translation. Through continuous advancement of plant chassis engineering, expression strategy design, and downstream processing technologies, we aim to help our clients achieve an optimal balance between biosafety, cost efficiency, and scalable production—accelerating the transition of plant-derived recombinant proteins from the laboratory to real-world applications. For more information on expression system selection and service details, please feel free to contact us.
Q1: What protein yields can be expected from plant expression systems?
A: Yields vary depending on the protein properties and the chosen expression system, ranging from milligrams to grams. Transient expression systems, such as in tobacco leaves, allow rapid production of research-scale protein within 2–3 weeks. Stable transgenic plants or plant cell suspension cultures are better suited for medium to large-scale production, enabling continuous generation of high-yield protein.
Q2: How is the purity and activity of plant-expressed proteins ensured?
A: We employ multi-step purification strategies, including affinity chromatography, ion exchange, and size-exclusion chromatography, to achieve protein purity meeting research or clinical standards. Purified proteins are assessed by SDS-PAGE, electrophoresis, and functional activity assays. Where needed, stability analysis and custom formulations can be provided to ensure optimal downstream performance.
Q3: Can clients provide specific design requirements for tags or fusion proteins?
A: Yes, we support a wide range of tags (e.g., His-tag, FLAG-tag, Fc-fusion) and fusion strategies to facilitate purification, detection, or functional enhancement. Tag type and positioning can be confirmed with the client during the design phase to ensure optimal expression and functional balance.
Q4: Can plant expression systems be used for oral protein therapeutics or functional foods?
A: Yes, certain plant systems, such as rice endosperm or microalgae, can produce proteins suitable for oral administration. This approach leverages the natural protective mechanisms of plant proteins to enhance stability in the digestive tract, offering potential for oral vaccines or functional food development.
Q5: How are intellectual property and confidentiality protected?
A: We strictly adhere to non-disclosure agreements (NDAs) and client IP protection requirements. All gene sequences, expression vectors, and production data remain the property of the client. Project materials are used solely for the commissioned R&D services, ensuring the security of both commercial and scientific information.
Copyright © Creative Biogene. All rights reserved.